The prognosis of early breast cancer (BC) relies on cell autonomous and immune parameters. The impact of the intestinal microbiome on clinical outcome has not yet been evaluated. Shotgun metagenomics was used to determine the composition of the fecal microbiota in 121 specimens from 76 early BC patients, 45 of whom were paired before and after chemotherapy. These patients were enrolled in the CANTO prospective study designed to record the side effects associated with the clinical management of BC. We analyzed associations between baseline or post-chemotherapy fecal microbiota and plasma metabolomics with BC prognosis, as well as with therapy-induced side effects. We examined the clinical relevance of these findings in immunocompetent mice colonized with BC patient microbiota that were subsequently challenged with histo-compatible mouse BC and chemotherapy. We conclude that specific gut commensals that are overabundant in BC patients compared with healthy individuals negatively impact BC prognosis, are modulated by chemotherapy, and may influence weight gain and neurological side effects of BC therapies. These findings obtained in adjuvant and neoadjuvant settings warrant prospective validation.

Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment / Terrisse, Safae; Derosa, Lisa; Iebba, Valerio; Ghiringhelli, François; Vaz-Luis, Ines; Kroemer, Guido; Fidelle, Marine; Christodoulidis, Stergios; Segata, Nicola; Thomas, Andrew Maltez; Martin, Anne-Laure; Sirven, Aude; Everhard, Sibille; Aprahamian, Fanny; Nirmalathasan, Nitharsshini; Aarnoutse, Romy; Smidt, Marjolein; Ziemons, Janine; Caldas, Carlos; Loibl, Sibylle; Denkert, Carsten; Durand, Sylvere; Iglesias, Claudia; Pietrantonio, Filippo; Routy, Bertrand; André, Fabrice; Pasolli, Edoardo; Delaloge, Suzette; Zitvogel, Laurence. - In: CELL DEATH AND DIFFERENTIATION. - ISSN 1350-9047. - 28:9(2021), pp. 2778-2796. [10.1038/s41418-021-00784-1]

Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment

Segata, Nicola;Thomas, Andrew Maltez;Pasolli, Edoardo;
2021-01-01

Abstract

The prognosis of early breast cancer (BC) relies on cell autonomous and immune parameters. The impact of the intestinal microbiome on clinical outcome has not yet been evaluated. Shotgun metagenomics was used to determine the composition of the fecal microbiota in 121 specimens from 76 early BC patients, 45 of whom were paired before and after chemotherapy. These patients were enrolled in the CANTO prospective study designed to record the side effects associated with the clinical management of BC. We analyzed associations between baseline or post-chemotherapy fecal microbiota and plasma metabolomics with BC prognosis, as well as with therapy-induced side effects. We examined the clinical relevance of these findings in immunocompetent mice colonized with BC patient microbiota that were subsequently challenged with histo-compatible mouse BC and chemotherapy. We conclude that specific gut commensals that are overabundant in BC patients compared with healthy individuals negatively impact BC prognosis, are modulated by chemotherapy, and may influence weight gain and neurological side effects of BC therapies. These findings obtained in adjuvant and neoadjuvant settings warrant prospective validation.
2021
9
Terrisse, Safae; Derosa, Lisa; Iebba, Valerio; Ghiringhelli, François; Vaz-Luis, Ines; Kroemer, Guido; Fidelle, Marine; Christodoulidis, Stergios; Segata, Nicola; Thomas, Andrew Maltez; Martin, Anne-Laure; Sirven, Aude; Everhard, Sibille; Aprahamian, Fanny; Nirmalathasan, Nitharsshini; Aarnoutse, Romy; Smidt, Marjolein; Ziemons, Janine; Caldas, Carlos; Loibl, Sibylle; Denkert, Carsten; Durand, Sylvere; Iglesias, Claudia; Pietrantonio, Filippo; Routy, Bertrand; André, Fabrice; Pasolli, Edoardo; Delaloge, Suzette; Zitvogel, Laurence
Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment / Terrisse, Safae; Derosa, Lisa; Iebba, Valerio; Ghiringhelli, François; Vaz-Luis, Ines; Kroemer, Guido; Fidelle, Marine; Christodoulidis, Stergios; Segata, Nicola; Thomas, Andrew Maltez; Martin, Anne-Laure; Sirven, Aude; Everhard, Sibille; Aprahamian, Fanny; Nirmalathasan, Nitharsshini; Aarnoutse, Romy; Smidt, Marjolein; Ziemons, Janine; Caldas, Carlos; Loibl, Sibylle; Denkert, Carsten; Durand, Sylvere; Iglesias, Claudia; Pietrantonio, Filippo; Routy, Bertrand; André, Fabrice; Pasolli, Edoardo; Delaloge, Suzette; Zitvogel, Laurence. - In: CELL DEATH AND DIFFERENTIATION. - ISSN 1350-9047. - 28:9(2021), pp. 2778-2796. [10.1038/s41418-021-00784-1]
File in questo prodotto:
File Dimensione Formato  
s41418-021-00784-1.pdf

accesso aperto

Tipologia: Versione editoriale (Publisher’s layout)
Licenza: Creative commons
Dimensione 5.84 MB
Formato Adobe PDF
5.84 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/355051
Citazioni
  • ???jsp.display-item.citation.pmc??? 36
  • Scopus 71
  • ???jsp.display-item.citation.isi??? 66
social impact